Live Quote · WSEBCX.WAHealthcare · Biotechnology

Bioceltix S.a.

$87.80▲ 0.11%(+$0.10)

TickerSpark Score

54/100

▌ Mixed

47

Valuation

20

Profitability

40

Growth

84

Health

80

Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BCX.WA research report →

52-Week Range43% of range

Low

$70.00

Current

$87.80

High

$111.00

Company Overviewbioceltix.com

About the company

Bioceltix S. A. engages in the development of stem cell-based biopharmaceuticals for veterinary use.

CEO: Lukasz Piotr Bzdzion
IPO: 2021
Employees: 44
HQ: Wroclaw, DS, PL

Price Chart

-17.48% · this period

Valuation

Market Cap: $485.73M
P/E: -26.45
P/S: 0.00
P/B: 7.19
EV/EBITDA: -23.28
Div Yield: 0.00%

Profitability

Gross Margin: 0.00%
Op Margin: 0.00%
Net Margin: 0.00%
ROE: -34.50%
ROIC: -27.91%

Growth & Income

Revenue: $0 · 0.00%
Net Income: $-15,159,087 · -1.75%
EPS: $-3.03 · 7.62%
Op Income: $-17,315,977
FCF YoY: 21.74%

Performance & Tape

52W High: $111.00
52W Low: $70.00
50D MA: $85.32
200D MA: $86.96
Beta: 1.03
Avg Volume: 6.19K

Get TickerSpark's AI analysis on BCX.WA

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Coverage · BCX.WA